Fujimoto M - Search Results

1

The wound/burn guidelines - 5: Guidelines for the management of lower leg ulcers/varicose veins.

Ito T, Kukino R, Takahara M, Tanioka M, Nakamura Y, Asano Y, Abe M, Ishii T, Isei T, Inoue Y, Imafuku S, Irisawa R, Ohtsuka M, Ohtsuka M, Ogawa F, Kadono T, Kawakami T, Kawaguchi M, Kono T, Kodera M, Sakai K, Nakanishi T, Hashimoto A, Hasegawa M, Hayashi M, Fujimoto M, Fujiwara H, Maekawa T, Matsuo K, Madokoro N, Yamasaki O, Yoshino Y, Le Pavoux A, Tachibana T, Ihn H; Wound/Burn Guidelines Committee. Ito T, et al. Among authors: fujimoto m. J Dermatol. 2016 Aug;43(8):853-68. doi: 10.1111/1346-8138.13286. Epub 2016 Mar 12. J Dermatol. 2016. PMID: 26973097

2

Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis.

Sato S, Hayakawa I, Hasegawa M, Fujimoto M, Takehara K. Sato S, et al. Among authors: fujimoto m. J Invest Dermatol. 2003 Apr;120(4):542-7. doi: 10.1046/j.1523-1747.2003.12097.x. J Invest Dermatol. 2003. PMID: 12648215 Free article.

3

Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis.

Furuse S, Fujii H, Kaburagi Y, Fujimoto M, Hasegawa M, Takehara K, Sato S. Furuse S, et al. Among authors: fujimoto m. J Rheumatol. 2003 Jul;30(7):1524-8. J Rheumatol. 2003. PMID: 12858452

4

Serum levels of tumor necrosis factor and interleukin-13 are elevated in patients with localized scleroderma.

Hasegawa M, Sato S, Nagaoka T, Fujimoto M, Takehara K. Hasegawa M, et al. Among authors: fujimoto m. Dermatology. 2003;207(2):141-7. doi: 10.1159/000071783. Dermatology. 2003. PMID: 12920362

5

Elevated circulating CD40L concentrations in patients with systemic sclerosis.

Komura K, Sato S, Hasegawa M, Fujimoto M, Takehara K. Komura K, et al. Among authors: fujimoto m. J Rheumatol. 2004 Mar;31(3):514-9. J Rheumatol. 2004. PMID: 14994397

6

Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells.

Sato S, Fujimoto M, Hasegawa M, Takehara K. Sato S, et al. Among authors: fujimoto m. Arthritis Rheum. 2004 Jun;50(6):1918-27. doi: 10.1002/art.20274. Arthritis Rheum. 2004. PMID: 15188368 Free article.

7

Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.

Sato S, Fujimoto M, Hasegawa M, Takehara K, Tedder TF. Sato S, et al. Among authors: fujimoto m. Mol Immunol. 2004 Nov;41(12):1123-33. doi: 10.1016/j.molimm.2004.06.025. Mol Immunol. 2004. PMID: 15482848 Review.

8

[A female case of hyper-IgM immunodeficiency syndrome with uncommon skin manifestations].

Asashima N, Fujimoto M, Jinnin M, Ihn H, Kikuchi K, Takamizawa M, Tamaki K. Asashima N, et al. Among authors: fujimoto m. Nihon Rinsho Meneki Gakkai Kaishi. 2004 Oct;27(5):350-5. doi: 10.2177/jsci.27.350. Nihon Rinsho Meneki Gakkai Kaishi. 2004. PMID: 15559325 Free article. Japanese.

9

Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis.

Hasegawa M, Fujimoto M, Takehara K, Sato S. Hasegawa M, et al. Among authors: fujimoto m. J Dermatol Sci. 2005 Jul;39(1):1-7. doi: 10.1016/j.jdermsci.2005.03.013. J Dermatol Sci. 2005. PMID: 15885984 Review.

10

Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response.

Matsushita T, Fujimoto M, Hasegawa M, Komura K, Takehara K, Tedder TF, Sato S. Matsushita T, et al. Among authors: fujimoto m. Am J Pathol. 2006 Mar;168(3):812-21. doi: 10.2353/ajpath.2006.050923. Am J Pathol. 2006. PMID: 16507897 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,526 results

Search Page

Filters